© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle


May 25, 2017

Finalists announced for this year’s New Investigator Award

With the judges, Bioanalysis Zone has announced the four finalists of the 2017 New Investigator Award.


Over the past months Bioanalysis Zone has been flooded with the community’s enthusiasm to recognize and promote the work of fellow early-career scientists working in bioanalysis. With the support of the sponsor Waters Corporation, the Zone is honored to offer nominees and winners of the New Investigator Award a springboard to help establish themselves in the exciting world of bioanalysis.


This year, the standard of all the candidates was incredibly high and the Zone would like to thank all the nominees and those who nominated. After much deliberation from the judges, Bioanalysis Zone isdelighted to announce the finalists for this year’s Award:

Swarnapali De Silva Indrasekara
Matthew Lockett
Michael Witting
Yu Shrike Zhang


In order to decide the winner, each finalist has prepared a short interview in which they share their research and the reasons why you should vote. Voting is now open and it is up to you to select a winner!


For any enquiries email n.maundrell@future-science.com






About Bioanalysis Zone


Since launching in 2011, Bioanalysis Zone has attracted over 6,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research exclusive interviews and commentaries.



About Future Science Group


Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio includes two imprints: Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.